29 results on '"Xia, Leilei"'
Search Results
2. PD38-12 NATIONAL PERFORMANCE OF LYMPHADENECTOMY FOR MUSCLE-INVASIVE UROTHELIAL CANCER AND AN EXPLORATORY ANALYSIS TO DEFINE OPTIMAL LYMPH NODE YIELD BASED ON SOUTHWEST ONCOLOGY GROUP S1011 TRIAL
3. V09-01 UPDATED EXPERIENCE ON MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER
4. MP34-19 ROLE OF SELF-ASSESSED SOCIAL SUPPORT AND SOCIAL DEPRIVATION INDEX IN PREDICTING COMPLICATIONS FOLLOWING RADICAL CYSTECTOMY
5. PD20-05 CORRELATES OF KNOWLEDGE OF CLINICAL TRIALS AMONG UROLOGIC CANCER SURVIVORS: FINDINGS FROM THE HEALTH INFORMATION NATIONAL TRENDS SURVEY
6. MP13-13 ASSOCIATION BETWEEN COMPLEXITY OF PELVIC SURGICAL FIELD AND OUTCOMES OF RADICAL CYSTECTOMY WITH URINARY DIVERSION
7. MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA
8. MP48-10 ANDROGEN DEPRIVATION THERAPY FOR NODE-POSITIVE PROSTATE CANCER AT RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION: CONTEMPORARY PRACTICE PATTERNS AND ASSOCIATED FACTORS
9. MP71-08 HIGH GRADE T1 UROTHELIAL CANCER WITH LYMPHOVASCULAR INVASION: NON-MUSCLE INVASIVE BLADDER CANCER OR NOT?
10. MP22-02 PATHOLOGIC AND SURVIVAL OUTCOMES FOLLOWING RADICAL CYSTECTOMY FOR "PROGRESSIVE" AND "DE NOVO" MUSCLE-INVASIVE BLADDER CANCER: A META-ANALYSIS STRATIFIED BY NEOADJUVANT CHEMOTHERAPY STATUS.
11. Associations between Hospital Volume and Outcomes of Robot-Assisted Radical Prostatectomy
12. PD09-04 TECHNOLOGY APPLICATIONS TO IMPROVE COMPLIANCE WITH HEMATURIA GUIDELINE RECOMMENDATIONS: ADDRESSING BARRIERS IN A LARGE ACADEMIC CENTER
13. MP12-03 COMPLICATIONS AFTER RADICAL CYSTECTOMY: UNDERSTANDING THE CONTEXT OF RECOVERY
14. National Variation in Opioid Prescription Fills and Long-Term Use in Opioid Naïve Patients after Urological Surgery
15. MP73-20 PREDICTORS OF SURGICAL REFERRAL FOR RECONSTRUCTION IN PATIENTS UNDERGOING MOHS SURGERY FOR SQUAMOUS CELL CARCINOMA OF THE MALE GENITALIA
16. MP66-06 PROGNOSTIC SIGNIFICANCE OF SARCOMATOID FEATURES IN METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND TARGETED THERAPY
17. MP78-16 PROGNOSTIC SIGNIFICANCE OF LYMPH NODE YIELD AT RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
18. MP41-15 DOES ROBOTIC CYSTECTOMY ACHIEVE ONCOLOGIC EFFICACY FOR LOCALLY ADVANCED BLADDER CANCER?
19. PD15-10 ASSOCIATION OF DELAYED ADJUVANT CHEMOTHERAPY WITH SURVIVAL AFTER RADICAL CYSTECTOMY FOR LOCALLY ADVANCED BLADDER CANCER
20. PD12-12 EARLY DISCHARGE FOLLOWING RADICAL NEPHRECTOMY DOES NOT INCREASE READMISSION RISK
21. MP83-02 LYMPH NODE DISSECTION AND SURVIVAL IN PATIENTS WITH CLINICAL T1 HIGH-GRADE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY
22. MP42-20 SAFETY AND FEASIBILITY OF NEXT-DAY DISCHARGE FOR MINIMALLY-INVASIVE PARTIAL NEPHRECTOMY - A NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM STUDY
23. MP41-05 IMPACT OF CLINICAL STAGING ON SURVIVAL FOR PATIENTS DOWNSTAGED FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY
24. PD15-05 EXTERNAL VALIDATION OF A DECISION-SUPPORT TOOL FOR BORDERLINE OPERABLE MUSCLE-INVASIVE BLADDER CANCER (MIBC) PATIENTS CHOOSING BETWEEN RADICAL CYSTECTOMY AND CHEMO-RADIOTHERAPY
25. MP86-03 THE RELATIONSHIP BETWEEN FRAILTY AND HEALTHCARE RESOURCE UTILIZATION FOLLOWING UROLOGICAL CANCER SURGERY
26. MP21-17 COMPARISON OF DIFFERENT LYMPH NODE STAGING SCHEMES FOR PREDICTING SURVIVAL IN PATIENTS FOLLOWING RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
27. MP78-08 IMPROVED SURVIVAL OF CYTOREDUCTIVE SURGERY IN ADDITION TO CHEMOTHERAPY FOR METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: RESULTS FROM THE NATIONAL CANCER DATA BASE
28. MP96-05 PRE-DISCHARGE PREDICTORS OF READMISSIONS AND POST-DISCHARGE COMPLICATIONS IN ROBOT-ASSISTED RADICAL PROSTATECTOMY
29. MP72-11 MODIFIED 5-ITEM FRAILTY INDEX IS ASSOCIATED WITH INCREASED HEALTHCARE RESOURCE UTILIZATION FOLLOWING ELECTIVE MINIMALLY INVASIVE RADICAL NEPHRECTOMY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.